Stocks and Investing Stocks and Investing
Fri, August 13, 2021
Thu, August 12, 2021
Wed, August 11, 2021
Tue, August 10, 2021

Salveen Richter Downgraded (BLUE) to Hold and Decreased Target to $23 on, Aug 10th, 2021


Published on 2024-10-27 17:35:36 - WOPRAI
  Print publication without navigation


Salveen Richter of Goldman Sachs, Downgraded "bluebird bio, Inc." (BLUE) to Hold and Decreased Target from $63 to $23 on, Aug 10th, 2021.

Salveen has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, all agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $35 on, Friday, July 16th, 2021
  • Yun Zhong of "Berenberg" Downgraded from Strong Buy to Hold and Held Target at $35 on, Thursday, July 1st, 2021